title: Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.
abstract: The expression of calpain small subunit 1 (Capn4) is correlated with the invasion of several types of tumors. However, the roles of Capn4 in non-small cell lung cancer (NSCLC) remain unclear. In this study, we found that the expression of Capn4 in NSCLC tissues was much higher than that in nontumorous samples. High levels of Capn4 expression were associated with lymph node metastasis and large tumor size in NSCLC patients. The 5-year overall survival rate in the Capn4(high) group was significantly lower than that in the Capn4(low) group. In multivariate analysis, Capn4 was identified as an independent prognostic factor for overall survival. Moreover, in an in vitro analysis, downregulation of Capn4 expression by siRNA suppressed the invasive potential of lung cancer cells. Finally, we demonstrated that Capn4 enhanced the invasion ability of lung cancer cells by upregulating the expression of matrix metalloproteinase 2. Our findings indicated that Capn4 may represent a potential therapeutic target and a novel prognostic marker of NSCLC.
authors: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
authors: Jie
authors: J
authors: Gu
authors: Feng-kai
authors: FK
authors: Xu
authors: Guang-yin
authors: GY
authors: Zhao
authors: Chun-lai
authors: CL
authors: Lu
authors: Zong-wu
authors: ZW
authors: Lin
authors: Jian-yong
authors: JY
authors: Ding
authors: Di
authors: D
authors: Ge
mesh_terms: D000368:Aged; D002154:Calpain / Q000235:genetics / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D045744:Cell Line, Tumor; D005260:Female; D055785:Gene Knockdown Techniques; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D008875:Middle Aged; D011379:Prognosis; D015854:Up-Regulation
chemical_list: D002154:Calpain; C527669:CAPNS1 protein, human; C522361:MMP2 protein, human; D020778:Matrix Metalloproteinase 2
references: PLoS One. 2013;8(1):e54619
references: 23349941
references: Cancer Res. 2003 Aug 1;63(15):4632-40
references: 12907643
references: Cancer Invest. 2010 Jul;28(6):661-9
references: 20394501
references: Int J Oncol. 1998 Jun;12(6):1343-8
references: 9592197
references: J Int Med Res. 2014 Apr;42(2):282-91
references: 24514433
references: J Biol Chem. 2001 Dec 21;276(51):48382-8
references: 11602605
references: J Cell Sci. 2005 Sep 1;118(Pt 17):3829-38
references: 16129881
references: Nat Rev Cancer. 2011 May;11(5):364-74
references: 21508973
references: J Thorac Oncol. 2007 Aug;2(8):706-14
references: 17762336
references: Mol Cell Biol. 2000 Jun;20(12):4474-81
references: 10825211
references: Histopathology. 2009 Mar;54(4):442-51
references: 19309396
references: J Biol Chem. 2008 Jul 25;283(30):21002-10
references: 18515801
references: Cell. 2009 Nov 25;139(5):871-90
references: 19945376
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Hepatology. 2009 Feb;49(2):460-70
references: 19053044
references: Lung Cancer. 2013 Aug;81(2):259-65
references: 23706417
references: Cancer Sci. 2014 Jun;105(6):630-8
references: 24703594
references: Gastroenterology. 2011 May;140(5):1629-41.e15
references: 21320503
references: Mol Cell Biol. 2013 Jun;33(12 ):2485-96
references: 23589330
references: Int J Cancer. 2010 Dec 15;127(12):2893-917
references: 21351269
references: Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53
references: 17291261
references: Nature. 2008 Nov 20;456(7220):409-12
references: 19020623
references: CNS Neurosci Ther. 2014 Jun;20(6):521-7
references: 24628706
references: J Pathol. 2014 Nov;234(3):316-28
references: 24962955
references: Physiol Rev. 2003 Jul;83(3):731-801
references: 12843408
references: Cancer. 2014 Mar 1;120(5):652-63
references: 24804299
references: Asian Pac J Cancer Prev. 2014;15(3):1085-91
references: 24606423